Study: Thiazolidinedione-statin combo may aid patients with diabetes

05/24/2011 | Renal and Urology News

A thiazolidinedione-statin combo reduced the levels of high-sensitivity C-reactive protein and improved the levels of fasting glucose and anti-inflammatory hormone adiponectin in participants compared with those who received a statin-placebo combo, experts reported at the annual meeting of the American Society of Hypertension. The findings suggest that the combination may curb systemic inflammation and onset of diabetes in high-risk patients, researchers added.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL